Anavex Life Sciences Announces Closing of $50 Million Registered Direct Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/23/2026
- Wall Street ends down as oil prices, Treasury yields rise
- BTIG’s Krinsky warns 2000-like signals are mounting
- HSBC remains max bullish on stocks, tells investors to lean into tech
- Analyst explains why the midterm outcome is a “fundamental non-event”
- Oil settles up around 4% as Iran's president vows to never surrender
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- On Holding sets 2029 financial targets, authorizes $1B share buyback
- Nasdaq reaches record high close, AI stocks rally
- Elmet Group signs tungsten offtake deal with Hemerdon Mine
- Meta bull case increasingly playing out, Mizuho says
Anavex Life Sciences (AVXL) PT Raised to $32.75 at Ladenburg Thalmann
June 28, 2021 12:33 PM EDTLadenburg Thalmann analyst Robert LeBoyer raised the price target on Anavex Life Sciences (NASDAQ: AVXL) to $32.75 (from $28.75) while maintaining a Buy rating as phase 2 PDD data exceeds previously established cutoff scores.
The analyst commented, "This morning, Anavex announced that the biomarker of response for... More
